A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

The present study was aimed at defining the antitumour activity of the cisplatin-paclitaxel-topotecan (CPT) weekly administration with G-CSF support in chemo-naive SCLC patients with extensive disease (ED-SCLC). Chemonaive ED-SCLC patients received cisplatin 40 mg/m(2), paclitaxel 85 mg/m(2), and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Frasci, G, Nicolella, G, Comella, P, Carreca, I, DeCataldis, G, Muci, D, Brunetti, C, Natale, M, Piantedosi, F, Russo, A, Palmeri, S, Comella, G, Panza, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363878/
https://www.ncbi.nlm.nih.gov/pubmed/11336465
http://dx.doi.org/10.1054/bjoc.2001.1741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363878/
https://www.ncbi.nlm.nih.gov/pubmed/11336465
http://dx.doi.org/10.1054/bjoc.2001.1741

Ejemplares similares